Warwick J. Britton

Royal Prince Alfred Hospital — Australia

Medicine · Health Sciences

71h-index18.8kcitations419works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(171), Mycobacterium research and diagnosis(108), Leprosy Research and Treatment(51), Immunotherapy and Immune Responses(44), Immune Response and Inflammation(41)

Publications419 total

Efficacy of Inhalable Endolysin Cpl-1 Formulations in Combination with Gentamicin or Endolysin Pal in a Murine Lung Infection Model
Pharmaceutical Research·2026Open Access
ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials
ACS Infectious Diseases·2025· 1 cited
Upper respiratory tract immunization with Pam2Cys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2
Frontiers in Immunology·2025Open Access
Host-protein biomarkers distinguish asymptomatic TB in an active case finding study
IJTLD OPEN·2025Open Access
Molecular landscape of respiratory infection: A large-scale, multi-centre blood transcriptome dataset
Scientific Data·2025· 1 citedOpen Access
Dr. Paul Roche AM
Leprosy Review·2025Open Access
An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity
npj Vaccines·2025· 5 citedOpen Access
Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosis
2025· 1 citedOpen Access
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis
European Journal of Clinical Microbiology & Infectious Diseases·2025· 1 citedOpen Access
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis
EBioMedicine·2025· 11 citedOpen Access
Analogue of the natural product ecumicin causes sustained growth inhibition of Mycobacterium tuberculosis under multiple growth conditions
Tuberculosis·2024· 7 citedOpen Access
Modular Total Synthesis and Antimycobacterial Activity of Rufomycins
Organic Letters·2024· 3 cited
Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones
2024Open Access
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants
EBioMedicine·2024· 6 citedOpen Access
A Single Chimeric Spike Antigen Induces Pan-Sarbecovirus Immunity
2024· 1 citedOpen Access
Synergistic oral beta-lactam combinations for treating tuberculosis
Journal of Applied Microbiology·2024Open Access
Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice
Vaccines·2024· 4 citedOpen Access
Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2
ACS Infectious Diseases·2024· 2 cited
A lipid nanoparticle-mRNA vaccine provides potent immunogenicity and protection against <i>Mycobacterium tuberculosis</i>
2024· 5 citedOpen Access
Dendritic cell–specific intercellular adhesion molecule‐3‐grabbing nonintegrin (DC‐SIGN) is a cellular receptor for delta inulin adjuvant
Immunology and Cell Biology·2024· 11 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Bernadette M. Saunders(10), Helen Briscoe(7), Guy B. Marks(7), Caroline Demangel(6), Andrew G. D. Bean(5), Carl G. Feng(5), Suran L. Fernando(4), Hak‐Kim Chan(4), Daniel R. Roach(3), Malcolm P. France(3), Umaimainthan Palendira(3), Ann J. Woolcock(3), Greg J. Fox(3), Ronald Sluyter(3), James S. Wiley(3), Sharon Shui Yee Leung(3), Nicholas B. Carrigy(3), Reinhard Vehring(3), Warren H. Finlay(3), Sandra Morales(3)